- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02010697
Nonsmokers Helping Smokers Quit (Project BEST)
11. februar 2020 opdateret af: Shu-Hong Zhu, University of California, San Diego
Mail Campaigns That Target Smokers or Nonsmokers Who Live With Smokers
This study examines whether nonsmokers can be mobilized to help smokers quit.
We will test, via mail campaign, whether targeting nonsmokers can be equally effective in increasing smokers' quit rate as targeting smokers directly.
The hypothesis is that both targeted interventions will lead to a higher quit rate than a control group, which receives one set of self-help materials.
Each of the targeted intervention groups receives 10 mailings.
Smoking status of all three groups will be measured at 3 and 7 months post randomization.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
This study examines the potential of enlisting nonsmokers to help smokers quit smoking.
Nonsmokers are the majority of the society.
If an intervention can be designed to mobilize nonsmokers to help smokers quit, then it has strong implications for increasing smoking cessation at the population level.
The conventional approach in smoking cessation is to target smokers directly.
This study aims to test whether targeting nonsmokers can be equally effective.
The study employs a three arm randomized design, in which a smoker-nonsmoker pair in the same household will be randomized into one of the three groups.
One group receives materials targeting the smoker in the household, one group receives materials targeting the nonsmoker, and the third group serve as a control group.
The intervention consists of mailed materials which include postcards, informational materials, CDs, DVDs, coupons for cessation-related incentives such as nicotine patches, and links to secured websites.
The mail campaign is augmented with brief phone calls to ensure receipt of mailings and to reinforce targeted messages.The mail campaign is augmented with brief phone calls to ensure receipt of mailings and to reinforce targeted messages.
At 3 and 7 months post randomization, project staff contact all participants to assess their smoking status.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
3125
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
California
-
San Diego, California, Forenede Stater, 92111
- University Of California San Diego
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år og ældre (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- 18 years or older
- A household with at least one smoker and one nonsmoker
- Valid contact information
- English proficiency, both speaking and reading
Exclusion Criteria:
- Insufficient contact information
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Messages targeting nonsmokers
Messages targeting nonsmokers include 10 mailings for nonsmokers sent over 10 weeks.
The mailed materials include postcards, informational materials, CDs, DVDs, coupons for cessation-related incentives such as nicotine patches, and links to secured websites.
The mail campaign is augmented with brief phone calls to ensure receipt of mailings and to reinforce targeted messages.
|
|
|
Eksperimentel: Messages targeting smokers
Messages targeting smokers include 10 mailings for smokers sent over 10 weeks.
The mailed materials include postcards, informational materials, CDs, DVDs, coupons for cessation-related incentives such as nicotine patches, and links to secured websites.
The mail campaign is augmented with brief phone calls to ensure receipt of mailings and to reinforce targeted messages.
|
|
|
Ingen indgriben: Usual care
one time mailing with a self-help quit kit
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Number of Participants Reporting 30-day Abstinence
Tidsramme: 7-months post enrollment
|
Assessment interview is conducted over the phone at 7-months post enrollment to determine 30-day abstinence.
The interview will cover, as appropriate, tobacco use, use of quitting aids, and pattern of quitting (including slips and relapse situations).
|
7-months post enrollment
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Support for Quitting
Tidsramme: At intake
|
The number of participants who felt they had "a lot" of support for quitting or staying quit.
|
At intake
|
|
Number of Participants Reporting 30-day Abstinence
Tidsramme: 3-months post enrollment
|
Assessment interview is conducted over the phone at 3-months post enrollment to determine 30-day abstinence.
The interview will cover, as appropriate, tobacco use, use of quitting aids, and pattern of quitting (including slips and relapse situations).
|
3-months post enrollment
|
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Counseling
Tidsramme: 7-months post enrollment
|
Did participants receive counseling
|
7-months post enrollment
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Samarbejdspartnere
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. december 2013
Primær færdiggørelse (Faktiske)
1. januar 2016
Studieafslutning (Faktiske)
1. januar 2016
Datoer for studieregistrering
Først indsendt
2. december 2013
Først indsendt, der opfyldte QC-kriterier
9. december 2013
Først opslået (Skøn)
13. december 2013
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
13. februar 2020
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
11. februar 2020
Sidst verificeret
1. februar 2020
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- UO1 CA154280 IRB #130764
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Messages targeting nonsmokers
-
Roswell Park Cancer InstituteIncuronAfsluttetKlinisk fase III kutan melanom AJCC v8 | Patologisk trin IIIB kutan melanom AJCC v8 | Patologisk fase IIIC kutan melanom AJCC v8 | Klinisk fase IV kutan melanom AJCC v8 | Patologisk trin IV kutan melanom AJCC v8 | Stage III blødt vævssarkom i stammen og ekstremiteterne AJCC v8 | Stage IIIA blødt vævssarkom... og andre forholdForenede Stater
-
Sichuan UniversityRekrutteringOndartet ascites | Ondartet peritoneal effusion | Serøse hulrumsmetastaserKina
-
Sichuan UniversityRekrutteringPleural effusion, ondartet | Peritoneal karcinom metastatisk | HER2 positive maligniteterKina
-
Sichuan UniversityRekrutteringDual-targeting CLDN18.2 og PD-L1 CAR-T til patienter med CLDN18.2-positive avancerede solide tumorerAvanceret solid tumorKina
-
BGI, ChinaFudan University; Shanghai 10th People's HospitalRekruttering
-
Beijing BiotechRekrutteringMetastatisk sygdom | Pancreas Ductal Adenocarcinom (PDAC) | Unresectable Locally AdvancedKina
-
City of Hope Medical CenterNational Cancer Institute (NCI)Trukket tilbageFlotetuzumab til behandling af patienter med tilbagevendende eller refraktær CD123 positiv blodkræftTilbagevendende Hodgkin-lymfom | Refraktært Hodgkin-lymfom | Akut leukæmi | Tilbagevendende akut lymfatisk leukæmi | Tilbagevendende kronisk myelogen leukæmi, BCR-ABL1 positiv | Refraktær akut lymfatisk leukæmi | Systemisk mastocytose | Tilbagevendende hæmatologisk malignitet | Hårcelleleukæmi | Kronisk myelogen... og andre forhold
-
Children's Oncology GroupIncuron LLCRekrutteringRefraktær lymfom | Ildfast malignt fast neoplasma | Tilbagevendende lymfom | Tilbagevendende malignt fast neoplasma | Tilbagevendende diffust indre pontinsk gliom | Metastatisk malign neoplasma i centralnervesystemet | Tilbagevendende primær malign neoplasma i centralnervesystemet | Refraktær primær... og andre forholdForenede Stater, Australien
-
BGI, ChinaWuhan Union Hospital, ChinaRekruttering
-
Beijing BiotechRekrutteringPancreas Ductal Adenocarcinom (PDAC) | Uresekabel lokal fremskreden eller metastatisk sygdomKina